The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-4-Bromo-2-(3-oxoprop-1-en-1-yl)phenyl 2-acetoxybenzoate ID: ALA4251440
PubChem CID: 145982903
Max Phase: Preclinical
Molecular Formula: C18H13BrO5
Molecular Weight: 389.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Oc1ccccc1C(=O)Oc1ccc(Br)cc1/C=C/C=O
Standard InChI: InChI=1S/C18H13BrO5/c1-12(21)23-17-7-3-2-6-15(17)18(22)24-16-9-8-14(19)11-13(16)5-4-10-20/h2-11H,1H3/b5-4+
Standard InChI Key: DKXTTYUDLLJSPZ-SNAWJCMRSA-N
Molfile:
RDKit 2D
24 25 0 0 0 0 0 0 0 0999 V2000
20.5522 -8.6383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5510 -9.4578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2591 -9.8668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9687 -9.4573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9659 -8.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2573 -8.2294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8430 -9.8658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1356 -9.4567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4276 -9.8647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1363 -8.6395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.2589 -10.6839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5511 -11.0924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9665 -11.0927 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5509 -11.9096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8422 -12.3137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8417 -13.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5498 -13.5397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2600 -13.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2570 -12.3118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9628 -11.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6724 -12.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3782 -11.8932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0878 -12.2984 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5507 -14.3569 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
8 10 2 0
3 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
17 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 389.20Molecular Weight (Monoisotopic): 387.9946AlogP: 3.81#Rotatable Bonds: 5Polar Surface Area: 69.67Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.01CX LogD: 4.01Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.34Np Likeness Score: -0.02
References 1. Lu S, Obianom ON, Ai Y.. (2018) Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer., 28 (17): [PMID:30037494 ] [10.1016/j.bmcl.2018.07.032 ]